XML 98 R65.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 29, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stockholders Equity Note [Line Items]        
Number of repurchased outstanding ordinary shares   1,348,865 2,772,811  
Payments for Repurchase of Common Stock   $ 127,017 $ 231,873 $ 200,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount   $ 321,553    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   2 years 3 months 21 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 706,629      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price $ 176.72      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 160,576      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 157,119      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value   $ 126,599    
Stock Repurchase Program, Authorized Amount   $ 500,000    
Share-based Payment Arrangement, Option        
Stockholders Equity Note [Line Items]        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   1,350    
Employee Shares Incentive Plan (the Plan") [Member]" | Share-based Payment Arrangement, Option        
Stockholders Equity Note [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   14,179